Article Details

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple ...

Retrieved on: 2021-03-08 07:18:45

Tags for this article:

Click the tags to see associated articles and topics

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple .... View article details on hiswai:

Excerpt

... to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody (i.e. be triple class refractory).

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up